INTRODUCTION
ACHNIL is a original research molecule of Venus Remedies which is known for his innovative and research product in the global pharmaceutical market. In the successful development of ACHNIL injection is a result of extensive research effort by the scientist at Venus Remedies. It has got patent in India and entire Europe. It is better known as research Molecule instead of merely saying a brand of Aceclofenac injection.
ACHNIL injection, a brand of Aceclofenac injection available in the once a day dosage form, first time in the world. Research technology used in ACHNIL injection design in such a way that it initiate result within 4-5 minutes due to initial burst release form and after that drug in release in controlled manner. ACHNIL maintains its concentration above therapeutic window up to 24 hrs. More over ACHNIL has less viscosity due to this patient feel less pain as compared to other preparations during Intramuscular use. ACHNIL not only reduces number of pricks but also drastically reduces the side effects associated with NSAIDs.
ACHNIL belongs to a class of Non Steroidal Anti-Inflammatory Drugs. It has more pronounced anti-inflammatory analgesic actions. ACHNIL has multi factorial mechanism of action which differentiate it as compared to commonly used other analgesic drug of same class. It is widely used to relieve acute and chronic inflammatory and painful conditions like rheumatoid arthritis, osteoarthritis, Low back pain, Ankylosing spondylitis, post traumatic pain, Post surgical Fibrosis conditions, oncology pain and other painful conditions.
Although Number of drugs are available in this category and is growing by 20% annually but still there is need of a drug which meets their medical management needs. They are searching for a drug that gives complete relief, immediate relief, consistent relief with least side effect. Adverse effect associated with the prolong used of NSAIDs are very well known and limits its use therefore inadequate outcomes has been observed.
ACHNIL, due to its research technology based on NDDS (Novel Drug Delivery System) technology will fill in the gap of long standing demand for better pain management. ACHNIL is clinically evaluated and find superior as compared to Diclofenac which is used in twice a day preparation. ACHNIL offer better anti-inflammatory and analgesic actions as compared with Diclofenac in all aspects.
